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Sunlmary 
Progression through the cell cycle is a tightly controlled process that integrates signals generated 
at the plasma membrane with the proteins that form the  cell cycle machinery. The current 
study chronicles the induction of cyclins, cyclin-dependent kinases (cdk), and cdk inhibitors in low 
density primary mouse B lymphocytes after anti-immunoglobulin plus interleukin 4  (IgM  + 
IL-4) stimulation. In this system, >85% of cells remain in the G0/G1 phase of cell cycle for an 
initial 24-h period,  followed by entry of up  to  50% of the  cells  into S phase,  commencing 
around 30 h  and peaking at 48 h. Extensive time course analyses  of these anti-IgM  +  IL-4- 
stimulated B cells revealed that the Gl-associated D-type cyclins D2 and D3 were induced by 
3 h after stimulation, and that cyclins E, A, and B were subsequently induced sequentially, be- 
ginning at mid-G1,  G1/S transition, and S phase,  respectively. The Gl-associated cyclin D1 
was not expressed at any stage  of the anti-Ig  +  IL-4-induced B  cell cycle, cdk2, cdk4, and 
cdk6 were induced during G1, whereas cell division cycle-2 (cdc2) was induced concomitantly 
with S phase. Irrespective of their expression, the kinases cdk2 and cdc2 were only active from 
S phase onwards,  suggesting that productive cyclin/kinase complex formation did not occur 
until that time. Cell cycle inhibitors p21 and p19 were induced by anti-Ig +  IL-4, peaking in 
expression at mid-G1 and S phase, respectively. Stimulation of low density B cells with anti-Ig 
+  IL-4 caused rapid down regulation of the p27  inhibitor,  however this protein was  reex- 
pressed at 54-96 h after stimulation. In contrast, B cells stimulated with anti-CD40, a stimulus 
which induces long-term B cell proliferation, permanently down regulated p27. These findings 
are consistent with the concept that p27 reexpression contributes to the G1 arrest that follows 
antigen receptor crosslinking. Low density B cells cultured in the viability-enhancing cytokine 
IL-4 alone also showed induction of D2 and D3 cyclin expression. However, the D2 expres- 
sion was transient, and the D3 expression was substantially lower than that observed in B cells 
induced to proliferate by anti-Ig +  IL-4. This partial  induction of D2 and D3 expression may 
explain IL-4's ability to promote B cell entry into G1 but not S phase of cell cycle, and further- 
more, its ability to truncate G1 progression when B cells are subsequently stimulated with anti-lg. 
A 
ntibody production by B lymphocytes is a fundamen- 
tal effector mechanism of the immune system. This re- 
sponse is critically dependent on the extent of B cell repli- 
cation that follows antigen stimulation,  since proliferation 
of activated B  cells  allows extensive expansion of initially 
small  numbers of antigen-specific B  cell precursors (1  and 
for a review see reference 2).  The regulation of antigen- 
initiated B  cell replication has been the subject of intense 
investigation for many years (for reviews see references 2-4). 
Such studies have included experiments that show that en- 
gagement of the antigen receptor using appropriate anti-lg 
antibodies causes essentially  all resting splenic mouse B cells 
to transit from GO to G1 in the cell cycle, with 50-60% of 
these cells completing the S, G2, and M  phases of cell cycle 
in a 40-48-h culture period (5, 6). Most of these B cells ap- 
pear to G1  arrest after this initial round of replication, al- 
though a small  subset may go through a second round of 
replication (7, 8).  These cell cycle events are accompanied 
by an array of biochemical reactions (9-11)  including ty- 
rosine phosphorylation (12,  13),  activation of protein ki- 
nase C  (14,  15), and calcium mobilization (16), all of  which 
occur rapidly after antigen cross-linking. 
The  proliferative  response  of B  cells  stimulated  with 
anti-Ig antibodies can be enhanced by coculture of the cells 
with the T  cell-derived cytokine IL-4 (17).  IL-4 is not an 
essential  activation signal in this system, since the prolifera- 
tion of B  cells  stimulated with supersaturating concentra- 
tions  of anti-Ig is  unaffected by anti-IL-4  antibodies  (7). 
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normal proliferative  response  to  in  vitro  stimulation  with 
supersaturating  concentrations  of anti-Ig (our  unpubfished 
data).  While  not an  essential cofactor, IL-4 enhances  anti- 
Ig stimulation  of B  cells by increasing  the  sensitivity of B 
cells to the anti-Ig signal (19), by increasing the proportion 
of B cells that enter S phase after anti-Ig stimulation  (8, 19), 
and by providing an anti-apoptotic signal (20) that accounts 
for the observed increase in B  cell viability (19, 21, 22). IL-4 
also  enables  a  large proportion  of B  cells  to  complete  the 
second  and  third  rounds  of the  cell  cycle after stimulation 
through  the  antigen  receptor  (8).  In addition  to  its ability 
to enhance  anti-Ig-induced  B  cell proliferation  and main- 
tain B  cell viability,  IL-4 has a  number of other direct  ef- 
fects on resting B  cells. Specifically, IL-4 causes an increase 
in B  cell size  (21,  23),  and upregulates  cell surface expres- 
sion of class  II MHC  antigens  (23,  24),  FceR  (22,  25,  26), 
and  IL-4 receptors  (27).  Furthermore,  B  cells  cultured  in 
IL-4 for 24  h  before  incubation  with  anti-Ig will  enter  S 
phase  12 h  earlier than non-IL-4-exposed  control  cultures 
(7,  28,  29).  IL-4 transmits signals to B  cells and  other cells 
via binding to an 1L-4-binding protein  (30, 31) that subse- 
quently causes activation of an associated signal-transducing 
protein known as the common y  chain  (32, 33).  The latter 
event initiates  a  chain  of biochemical  reactions,  including 
activation  of the Jak3  tyrosine  kinase  (34,  35),  which  in 
turn phosphorylates Stat6  (36). 
Whereas  seemingly  much  is  known  about  biochemical 
reactions that become triggered in the first minutes-to-hours 
after a B lymphocyte is stimulated with anti-Ig +  IL-4, lit- 
tle  is known  of the  ensuing intracellular  events  that  com- 
prise  the  remainder  of the  40-48-h  cell  cycle  period.  In 
particular, the early biochemical events described above are 
yet to be integrated with the family of cyclins, kinases, and 
inhibitors  that comprise the cell cycle machinery responsi- 
ble for regulating  cellular replication.  The  cyclins are pri- 
mary regulators of progression through  the cell cycle, serv- 
ing as  regulatory  subunits  for a  family of serine/threonine 
kinases known  as the cyclin-dependent  kinases or cdk 1 (for 
reviews see references 37, 38).  Cyclins D  and E, with their 
associated  kinase  partners,  control  cell  cycle  checkpoints 
that  occur early and  late in  G1,  respectively  (39-41).  Cy- 
clin  A/cdk  complexes are active initially at the  onset  of S 
phase and throughout  G2 (42, 43). The induction  ofcyclin 
B  during  S  phase,  and  subsequent  accumulation  of cyclin 
B/cell division cycle-2 (cdc2) complexes at G2, control en- 
try into  mitosis  (for reviews see  references  44,  45).  Thus, 
the  sequential  progression  through  the  cell  cycle  is  ulti- 
mately controlled by the temporal induction  and activation 
of a  series  of different  cyclin/cdk  kinases.  The  enzymatic 
activity ofcyclin/cdk complexes can be modified by associ- 
ation with a variety of inhibitory molecules by mechanisms 
that  are  not  well  understood  (for  a  review  see  reference 
46).  The inhibitors  can  be divided  into  two  groups,  those 
1Abbreviations used in  this paper: cdc2, cell division cycle; cdk, cyclin- 
dependent kinase; Rb, retinoblastoma. 
that  bind  multiple  cyclin/cdk  complexes  (e.g.,  p27  and 
p21)  and thus  are broad regulators  of cell cycle,  and  those 
that  have  a  preference  for  Gl-associated  D  cyclin/cdk 
complexes (INK4 family, e.g., p19).  These inhibitory mol- 
ecules, by virtue of their ability to modulate kinase activity, 
are potent cell cycle regulators. 
In this study, we explore the induction  of cell cycle reg- 
ulatory proteins  in normal murine  B  lymphocytes that are 
induced  to proliferate by cross-linking their antigen  recep- 
tors in the presence of the viability-enhancing cytokine IL-4. 
Our  data indicate  that proliferating mouse B  lymphocytes 
do  not  express  cyclin  D1,  but  otherwise  exhibit  a  typical 
cell cycle "clock" of cyclins, cdk, and inhibitors. 
Materials and Methods 
Mice.  8-10-wk-old BALB/c mice were obtained from Simon- 
sen (Gilroy, CA) and were used as a source of low density splenic 
B cells throughout this study. 
Reagents.  Antibodies used in this  study were monoclonal rat 
anti-mouse  cyclins  D3  and  D2,  mouse  anti-mouse  cyclin  D1, 
and rabbit anti-mouse cyclins E, A, and B, p27, p21, p18, cdk2, 
cdk4, and cdk6; these reagents were purchased from Santa  Cruz 
Biotechnology (Santa  Cruz,  CA). The mouse anti-mouse cdc-2 
and mouse anti-human-retinoblastoma  (Rb) antibodies used for 
Western blotting were purchased from PharMingen  (San Diego, 
CA). Horseradish peroxidase--conjugated  anti-rat, rabbit, and mouse 
secondary reagents were purchased  from Amersham Corp.  (Ar- 
lington Heights, IL). Additional antibodies against  cdk4 and p19 
were kindly provided by Dr.  Charles Sherr (St. Jude  Children's 
Research Hospital, Memphis, TN). Polyclonal rabbit anti-mouse 
p27  was kindly provided  by Drs.  Hideo  Toyoshima and  Tony 
Hunter (The Salk Institute, San Diego, CA). The anti-cdc2 anti- 
body used for immunoprecipitations was purchased from GIBCO 
BRL (Gaithersburg, MD). The rabbit anti-mouse cdk2 was pre- 
pared as described previously (47). The substrate for the kinase as- 
say,  histone  H1,  was  purchased  from  Boehringer  Mannheim 
Corp.  (Indianapolis,  IN). The affinity-purified F(ab')2  goat anti- 
mouse lg/Vl used to stimulate B cells was purchased fronl Cappd 
(Durham, NC), and the recombinant mouse IL-4 was produced 
in house at DNAX Research Institute.  The rat anti-mouse mono- 
clonal  anti-CD40  antibody was described  previously  (48).  The 
HT-2 proliferation bioassay  used to quantitate  IL-4 activity was 
performed as described elsewhere (48), with a unit of activity de- 
fined  as  the  amount  of cytokine  producing  50%  maximal  re- 
sponse. 
Purification qfl Low Density B Cells.  To isolate  splenic  B  cells, 
single  cell  suspensions  were prepared from spleens  of unprimed 
mice as described in detail  elsewhere (19, 48).  Briefly, red blood 
cells were lysed using red blood cell lysis buffer (Sigma Chemical 
Co., St. Louis, MO) according to the manufacturer's instructions. 
The  cells  were  then  stained  using  anti-Thy-1  (NEN  Research 
Products,  Wilmington,  DE)  and anti-CD4  (RL172)  for 20  mm 
on ice, followed by incubation in rabbit complement (Cedarlane 
Laboratories Ltd., Hornby, Ontario, Canada) at 37~  for 45 min. 
Low density B cells were then isolated by density gradient cen- 
trifugation  using a  discontinuous  gradient  composed of 85,  65, 
and 50% Percoll  (Sigma Chemical Co.) and centrifuging at 1,500 ,~ 
tbr 20 rain with the brake off. Cells between 50 and 65% Percoll, 
corresponding  to  a  density  range  of 1.062-1.0819  g/ml,  were 
collected for experiments. These cells were >90% lg bearing and 
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density centrifugation, containing most of the large,  low density 
B lymphocytes. 
In  Vitro Stimulations and Whole Cell Lysate Preparation.  50-ml 
cultures  were set up at  106 B cells/ml in 75 cm  2 flasks (Becton 
Dickinson & Co., Lincoln Park, NJ) and stimulated with 10 txg/ml 
F(ab')2 anti-IgM with or without 100 U/ml II.-4 or with 100 U/ml 
IL-4 alone for the initial time course experiments.  Additional cul- 
tures  were set up using anti-IgM (25  ~g/mi) or anti-CD40  (25 
~g/ml) in the absence  of IL-4. All stimulations  were carried  out 
in supplemented tLPMI (designated cRPMI) containing 10% FCS 
(JtL  Scientific,  Woodland,  CA),  5  X  10 -s  M  2-ME  (Poly- 
sciences, Inc., Warrington, PA), 2 mM glutamate  OK Scientific), 
10 mM Hepes buffer (Irvine Scientific,  Santa Ana, CA), 100 U/ 
ml  penicillin,  and  100  btg/ml  streptomycin  (Irvine  Scientific). 
Cells were stimulated  for the times  indicated.  After stimulation, 
cells were recovered, washed  three  times  in cold PBS,  divided 
into three pellets,  and stored at  -80C for later  use  in Western 
blotting and in vitro kinase assays. When all the time points were 
collected, one pellet from each time point was lysed in NP-40 ly- 
sis buffer (1% NP-40, 250 mM NaCI, 1 mM Hepes, pH 7.5, and 
1 mM  dithiothreitol  [DTT;  United  States  Biochemical  Corp., 
Cleveland, OH]) with protease  inhibitors  added (final concentra- 
tion,  5 p.g/ml aprotinin  [Sigma Chemical Co.],  125  Ixg/ml Pe- 
fabloc [Boehringer Mannheim Corp.], 5 ~g/ml leupeptin [Sigma 
Chemical Co.], and 5 I~g/ml pepstatin  (Sigma Chemical Co.]). 
Protein concentrations were calculated  using a Protein Assay kit 
(Bio-Rad Laboratories,  Hercules, CA) according to the manufac- 
turer's procedures.  An equal  volume of 25<  SDS sample  buffer 
(Novex, San Diego, CA) with 2-ME was then added to the total 
cell  lysates. 125  ~g  of h/sate  was  run per  time  point  on  12% 
Novex reducing gels according to the manufacturer's suggested 
protocol (6% gels were used to detect the P,.b protein), and trans- 
ferred onto Immobilon polyvinylidene difluoride  (PVDF) mem- 
branes  (Millipore,  Bedford, MA) at 30 V overnight at 4~  P3X 
or NIH3T3 cells were used as positive controls on all gets. 
In  Vitro Kinase Assay.  cdk2-  and  cdc2-dependent  kinase  as- 
says were performed using the histone substrate according to pro- 
cedures described elsewhere  (49). Briefly,  frozen pellets  were ly- 
sed in  1 ml 0.1%  NP-40 lysis buffer containing 50 mM Hepes, 
pH 7.0, and 250 mM NaCI in the presence of the above protease 
inhibitors.  Protein  concentration  was  calculated  as  described 
above, and 200 Ixg of total protein was used for each kinase assay. 
Briefly,  lysates  were  precleared  with  normal  rabbit  serum  fol- 
lowed by Zysorbin (Zymed Laboratories  inc.,  South San  Fran- 
cisco, CA). I  Ixg of anti-cdk2, anti-cdc2, or normal rabbit  serum 
was added to the lysate and incubated at 4~  for 4 h with rock- 
ing.  Protein  G  beads  (Pharmacia,  Milwaukee,  WI) were added 
and the lysates were rotated in the cold for another hour. Immu- 
noprecipitates  were washed four times in lysis buffer followed by 
two washes in kinase buffer (50 mM Tris, pH 7.4, 10 mM MgCL_, 
and 1 mM DTT). The kinase reaction was carried  out in a 50-1xl 
volume containing 2.5  txg histone  H1  and 5  txCi ~-[32p]gATP 
(Amersham Corp.) per reaction. R.eactions proceeded for 30 rain 
at  room temperature  with  rocking.  Samples  were  run  on  12% 
Novex precast  gels, fixed for 10 rain in 50% methanol and 10% 
acetic acid, dried, and exposed to film for 3 h at room temperature. 
Cell Cycle Analysis.  Cell cycle analyses were performed using 
a modification of the method described by Crissman  et al.  (50). 
Aliquots  of stimulated  cells were  taken  at  times  indicated  and 
washed twice in PBS.  Single  cell suspensions  were added drop- 
wise to ice cold 100% ETOH while vortexing, and stored at 4~ 
overnight.  Cells were then centrifuged and resuspended in pro- 
pidium  iodide/RNase  A  solution  (10  Ixg/rnl  [Sigma  Chemical 
Co.] and 250 p,g/ml [United States Biochemical Corp.], respec- 
tively),  followed by incubation at 37~  for 30 min.  Viable  cells 
were analyzed by CellFIT (Becton Dickinson Immunocytometry 
Systems,  San Jose,  CA) software  and the proportion of cells in 
each phase of cell cycle was calculated. 
[3H]Thymidine Incorporation.  200  Ixl  aliquots  (2  X  10  S total 
cells) of  stimulated  cells was placed in 96-well flat bottom plates at 
times indicated and pulsed for 45 nfin with 1 IxCi [3H]thymidine 
(Amersham Corp.). Cells were harvested  and incorporated counts 
per minute were counted using a PHD cell harvester  (Cambridge 
Technology Corp., Cambridge, MA). 
Results 
Large B  Cells Enter S phase at ,'~  h after Stimulation  with 
Anti-IgM +  IL-4.  To  study  the  induction  of cell  cycle 
regulatory proteins in anti-IgM-stimulated B  lymphocytes, 
we  used  a population  of B  lymphocytes that was purified 
by  negative  selection  from spleens  of unprimed  BALB/c 
mice.  The  resultant  B  cell  population  was  enriched  for 
large, low density B  cells and represented "~60% of the to- 
tal B  cells recovered after density centrifugation. This pop- 
ulation was highly purified for B lymphocytes, since 90% of 
cells coexpressed B220 and IgM membrane proteins. These 
enriched large B  cells were selected for our studies  rather 
than  highly  purified  small  dense  resting  B  cells  since  the 
low yield of the latter cells, together with their marked sus- 
ceptibility  to  rapid  death  in vitro,  severely  restricted bio- 
chemical  analyses:  Comparative  studies  indicated  that  the 
enriched  large B  cells  entered  S phase  of cell cycle ,'~  h 
earlier  than  highly purified  small  dense  B  cells  under  the 
experimental  conditions  employed,  but  otherwise  exhib- 
ited  essentially  identical  growth  characteristics  (data  not 
shown).  The cell cycle status  of the  starting population  of 
enriched large B  cells  was  evaluated by propidium iodine 
staining and FACS  |  analysis (Becton Dickinson &  Co.), as 
described in detail elsewhere  (19). These analyses indicated 
that  in several  independent  preparations  of low density B 
cells,  the majority of cells (i.e.,  85-96%) was in the G0/G1 
phase of cell cycle (data not shown). 
Enriched large B cells were cultured at 106/ml and stim- 
ulated with  10  ~g/ml anti-IgM plus  100 U/ml  IL-4. Cell 
aliquots were collected at 0, 3, 6, 9,  12, 15,  18, 24, 30, 36, 
48,  54, 62,  76, and 96 h  after stimulation for analysis. Cell 
cycle status of the cells was monitored by propidium iodine 
staining and FACS  |  analysis, and DNA synthesis was mea- 
sured  by  [3H]thymidine  incorporation.  Both  approaches 
revealed that,  in all experiments  evaluated,  a large propor- 
tion  of cells  commenced entry  into  S  phase  of cell  cycle 
"~  h  after stimulation  (a  typical experiment  is shown in 
Fig. 1). Peak [3H]thymidine incorporation occurred at 48 h 
after stimulation when "~60% of the cells were found in the 
S, G2, or M  phase of cell cycle. As previously described (8), 
a  large  proportion  of low  density  B  cells  progress  to  the 
second and even third rounds of the cell cycle when stimu- 
lated with anti-IgM  +  IL-4 resulting in the high  [3H]thy- 
midine  incorporation  detected  at  54-72-h  time  points. 
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Figure  1.  Cell cycle status of low density primary mouse B lympho- 
cytes after stimulation with anti-lgM  +  IL-4. I(P cells/ml were stimu- 
lated with 10 Ixg/ml anti-lgM plus 100 U/ml IL-4. 200/.tl aliquots were 
taken at 0, 3, 6, 9, 12, 15, 18, 24, 30, 36, 48. 54, 62, 74, and 96 h after 
stimulation and pulsed with 10 ~Ci [3H]thymidine in 96-well flat bottom 
plates for 45 rain (top). To perform cell cycle analysis, 106 cells were re- 
moved at times indicated, stained with propidium iodine, and analyzed by 
flow cytometry. The proportion of cells in each phase of cell cycle was 
determined using CellFIT software (bottom). Similar results were obtained 
in a second independent experiment. 
This  analysis  of the  anti-Ig-induced  B  cell  cycle  is  highly 
consistent with similar studies described  previously by De- 
Franco, A. et al.  (5, 6). 
Induction  of G 1-associated Cydins and cdk in B  Cells Stimu- 
lated with Anti-IgM +  IL-4.  In other cell systems, the D-type 
cyclins and their kinase partners cdk4 and cdk6 are the ear- 
liest  complexes  induced  as  cells  leave quiescence,  and  are 
therefore believed to play a critical role in exit from GO (for 
a  review  see  reference  37).  To  evaluate  this  phase  of cell 
cycle in primary B  lineage  cells,  purified large B  cells that 
had been stimulated in vitro for different time periods with 
anti-IgM +  IL-4 were lysed, and their intracellular proteins 
analyzed for expression  of Gl-associated cell cycle regula- 
tory proteins by Western blot analysis. Cyclins D2  and D3 
were usually not detected in unstimulated B cells; however, 
they were induced  rapidly (i.e., by 3  h)  and synchronously 
after stimulation,  and  thereafter  exhibited  a protracted  ap- 
pearance throughout  the entire B cell cycle (Fig. 2 A). Cy- 
clin  D2  migrated  as  a  single  species  throughout  the  time 
course, reaching peak levels by 6 h  and remaining constant 
throughout  the  time  course  until  96  h.  In  contrast,  acti- 
vated B  cells expressed multiple  forms of cyclin D3 at dif- 
ferent stages of cell cycle (Fig.  2 A). The functional  signifi- 
cance of this heterogeneity is yet to be established. 
In contrast to cyclins D2 and D3,  cyclin D1  was not de- 
tected  at  any  time  point  after  stimulation  of B  cells  with 
anti-IgM  +  IL-4 (Fig.  2 A). Control  experiments revealed 
that  the  sensitivity  of cyclin D1  detection  on  our  experi- 
ments was ~3  ng (our unpublished  data).  Our finding that 
cyclin D1  was not induced in activated B  lymphocytes was 
supported by separate experiments showing that none of 13 
cell  lines  derived  from  murine  B  cell  malignancies  ex- 
pressed cyclin D1  (not shown). These data together suggest 
that proliferating mature  murine  B  cells do  not  utilize  cy- 
clin D1  for cell cycle progression. 
The  preferred  kinase  partners  for  the  D-type  cyclins  are 
cdk4 and cdk6.  When B  cells stimulated  with  anti-IgM  + 
IL-4  were  analyzed  for  cdk  expression,  the  data  showed 
that both cdk4 and cdk6 were upregulated or induced early 
in  G1,  at 9  and  3  h,  respectively  (Fig.  2  /3). In other  cell 
systems, the binding of D-type cyclins to its kinase partners 
results in the appearance of an active kinase that is believed 
to phosphor/late  Rb,  allowing release  of bound  transcrip- 
tion  factors such  as  E2F  that  are  required  for the  entry  of 
cells into S phase (51-55).  Since attempts to specifically as- 
say this kinase activity in our experiments were unsuccess- 
ful  technically,  we  employed  an  alternative  approach  of 
monitoring  the  appearance  of endogenous  phosphor/lated 
P,.b  after B  cell activation.  Our  experiments  indicated  that 
the first detectable  in vivo phosphorylation  of the endoge- 
nous  tLb after anti-IgM  +  IL-4 stinmlation  of B  cells  oc- 
curs at  18  h  (Fig.  2  C),  some  15  h  after the appearance  of 
the D-type cyclins and  cdk6,  and 9  h  after the appearance 
ofcdk4 (Fig. 2 A). By 24 h, there is a slight upward mobility 
shift in the t~b gene product,  and nmltiple phosphorylated 
forms can be seen at later time points (Fig.  2  C-). At 96 h after 
stimulation, a time when the cells have exited the cell cycle 
in this anti-Ig stimulation  system (see Fig.  1), the R.b gene 
product returns to a hypophosphorylated form (Fig. 2  C). 
Induction  of G1/S-,  S-,  and  G2/M-associated  cyclins,  cdk, 
and Associated Kinase Activity in B  Cells Stimulated with Anti- 
Ig +  IL-4.  In other  cell systems, the  G1/S  interphase  of 
cell cycle, and subsequent progression to G2 and M  phases, 
are regulated by cyclins E, A, and B  and by their preferred 
kinase partners cdk2 and cdc2 (for reviews see references in 
37,  38).  The expression  of these  cell cycle regulatory pro- 
teins  in  normal  B  cells  stimulated  with  anti-IgM  +  IL-4 
was  evaluated  by Western  blot  analysis  of activated  B  cell 
lysates.  Cyclin  E,  a  regulator  that  is  required  for  cells  to 
transit  the  G1/S  interphase  (39,  41),  was  first  induced  at 
~9  h  after stimulation  (Fig.  3  A),  i.e.,  some  6  h  after D2 
and D3  induction  (Fig.  2 A).  Like the  D-type cyclins, cy- 
clin E  is also detected  throughout  the  remaining  96-h  re- 
sponse  period.  The  protracted  appearance  of cyclin  E  in 
this time course is likely the consequence of a large propor- 
tion of the cells entering subsequent  rounds  of the cell cy- 
cle.  Cyclin A, a regulator that is intimately associated with 
DNA  replication  (for a  review see reference  56),  was first 
detected  at 24  h  (Fig.  3  A), just  before  the  entry  of cells 
into S phase (see Fig.  1).  Cyclin B, which is normally asso- 
ciated with G2/M,  was first detected  after cyclin A  induc- 
tion,  at about 30 h  after stimulation  (Fig.  3 A). Expression 
of cdk2, the preferred kinase partner for cyclins E  and A, is 
upregulated  in  GI  and reaches  maximal expression  during 
S phase (Fig.  3  B, top). Expression of cdc2, the kinase part- 
ner for cyclin B  and to a lesser extent cyclin A, is induced 
at ~30  h  (Fig.  3  C,  top),  concomitantly  with  the  entry  of 
ceils into S phase (see Fig.  1). 
In  the  case  of cdk2  and  cdc2,  effective  cyclin/kinase 
4t0  Cell Cycle Regulation in B Lymphocytes Figure 2.  Induction ofGl-associated  cyclins, kinases,  and Rb. Western blots were prepared from lysates  of low density splenic B cells  stimulated as de- 
scribed in Fig. 1. 125 ~g of whole cell lysates  from each time point was loaded onto SDS-PAGE gels, along with lysates  from P3X or NIH-3T3 routine 
(cyclin DI only) or C33A human cells as positive controls. The gels were run for 1.5 h and transferred onto membranes for 24 h at 4~  The blots were 
blocked, incubated in specific  antibody preparations against cyclins  D1, D2, D3 (A), cdk4, cdk6 (B), or Rb (C), followed by horseradish  peroxidase--con- 
jugated secondary antibodies. Enhanced chemiluminescence was performed and the blots were exposed to film for a l-rain initial exposure followed by a 
15-30-rain reexposure. The time in hours after stimulation is indicated. Similar  results were obtained in a second independent experiment. 
complex formation can be monitored via phosphorylation of 
the substrate histone H1  (49).  The in vitro histone HI  ki- 
nase assay was performed on B  cell lysates collected at the var- 
ious time points.  Specific cyclin/cdk complexes were  im- 
munoprecipitated  using  anti-cdk2  or  anti-cdc2.  Fig.  3  B 
demonstrates that, despite the presence of cdk2 early in the 
cell cycle, no kinase activity was detected until N24 h  after 
stimulation, i.e., immediately before the entry into S phase 
(see Fig. 1). In contrast, cdc2-associated kinase activity cor- 
related with protein expression, with  kinase activity being 
detectable just before S phase entry (Fig. 3  C). The peak of 
cdc2-associated  kinase  activity lagged  behind  the  peak  in 
cdk2-associated kinase activity by 6 h. 
Induction of Cell  Cycle Inhibitors in B  Cells Stimulated  with 
Anti-Ig +  IL-4.  The enzymatic activity ofcyclin/cdk com- 
plexes can be modulated by a group ofheterologous inhib- 
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itors  (for a  review see  reference  46).  Two  inhibitors, p27 
and p21, are broadly acting with reactivity toward a variety 
of cyclin/kinase complexes.  As shown  in  Fig. 4  A, p27  is 
expressed  at  significant  levels  in  unstimulated  normal  B 
cells. After stimulation of the B  cells with anti-Ig +  IL-4, 
the  levels of p27  inhibitor decrease  dramatically over the 
first 12 h,  and reach their lowest level at 48 h  (Fig. 4  A), a 
time point that correlates with  the peak of [3H]thymidine 
incorporation (see Fig.  1).  Expression of the p27  inhibitor 
is upregulated again after 48  h  (Fig. 4  A), correlating with 
diminished DNA  replication as well as an accumulation of 
cells arrested in  G1  phase  (see Fig.  1).  Since p27  has been 
shown to mediate G1 arrest in overexpression systems (57), 
we  suspected that  the  reexpression of p27  may contribute 
to  the  well  documented  G1  arrest  that  terminates  B  cell 
proliferation in response to anti-IgM stimulation (7, 8). To Figure 3.  Induction ofG1/S-, S-, 
and  G2/M-associated  cyclins, ki- 
nases, and kinase activities. Western 
blots of  stimulated B cell  lysates  were 
incubated  with  specific antibodies 
against cyclins E, A, B (A), or cdc2 
and cdk2 (B and  C,  top), and pro- 
cessed as described. P3X  or C33A 
cells were used as positive controls. 
The time in hours after stimulation 
with anti-lg +  IL-4 is indicated. 200 
txg of total cell lysates from B lym- 
phocytes stimulated as described in 
Fig. I  was used to perform in vitro 
kinase  assays  (B  and  C,  bottom). 
cdk2-  or  cdc2-imnmnoprecipitated 
complexes were isolated, and kinase 
reactions were performed in 5t) mM 
Hepes plus protease inhibitors, with 
the  addition  of 5  p,  Ci ",/-[32p]ATP 
and 2.5  Ixg histone per reaction as 
substrate. Reactions were perfomled 
at room temperature tbr 30 min, run 
on 12% gels, the~l dried and exposed 
to film for 3 h at room temperature. 
P3X  cells were  used  as  a  positive 
control.  The  time  in  hours after 
stimulation is indicated. 
evaluate this proposal, we  compared the levels of p27  ex- 
pression after antigen receptor cross-linking with the level 
of p27 expression in B  cells stimulated with anti-CD40 an- 
tibodies, an activator capable of inducing long-term B  cell 
proliferation (58).  In these experiments, IL-4 was not used 
as a costimulant, since IL-4 delays the G1 arrest that follows 
anti-lgM stimulation. As seen in  Fig. 4  B,  p27  is only up- 
regulated after mitosis in B  cells stimulated with  anti-lgM 
and not in B  ceils stimulated with anti-CD40. B  cells stim- 
ulated  with  the  long-term  stimulus  anti-CD40  showed 
prolonged  downregulation  of  p27  inhibitor  (Fig.  4  B). 
These findings are consistent with the suggestion that p27 
contributes  to  the  G1  arrest that  follows antigen  receptor 
cross-linking. 
Fig. 4 A  also documents the expresson of other cell cycle 
inhibitors in activated B  cells, p21  is only weakly detectable 
at  time  zero,  but  is  induced  as  cells  enter  cell cycle  and 
fbund at highest levels corresponding to mid-G1  and G1/S 
interphase,  i.e.,  from  15  to  36  h  after  stimulation.  The 
INK4  family  of inhibitors  is  specific for  cdk4  and  cdk6, 
thus affecting D-type complex activity (for a review see ref- 
erence  46).  Analysis of one  such  inhibitor,  p19,  showed 
that it is initially induced during late G1, with continued ex- 
pression during S and G2/M phases, and can be detected at 
maximal levels by 48 h  after stimulation (Fig. 4 A). The po- 
tential significance of these observations is discussed below. 
IL-4 Alone Causes  Partial Induction  of Cyclins  D2 and D3 in 
Large B  Cells.  As described above, IL-4 is a  T  cell--derived, 
viability-enhancing cytokine that potentiates anti-Ig-induced 
B  cell proliferation (17),  and  truncates  by ~12  h  the  G1 
phase  of cell  cycle  when  IL-4-treated B  cells  are  subse- 
quently stimulated with anti-Ig (7, 28,  29). The above ex- 
periments characterize the cell cycle regulatory proteins in- 
duced in normal B  cells stimulated with anti-IgM  +  IL-4. 
To determine the contribution that IL-4 may be making to 
these data, similar experiments were conducted comparing 
B  cells stimulated with IL-4 alone, anti-Ig alone, or a com- 
bination of the two. The comparison was restricted to anal- 
ysis of the Gl-associated D  cyclins, since the IL-4 stimulus 
does not  drive B  cells beyond the  G1  phase  of cell cycle. 
Low density B  cells were stimulated with either  10  Ixg/rnl 
of anti-IgM  or  100  U/ml  of IL-4,  and  time  points  were 
collected as described above. The same cell preparation was 
also stimulated with  anti-IgM  +  [L-4 for direct compari- 
son. In this particular experiment, contrasting those above, 
trace  amounts  of cyclin D2  as well as the  faster migrating 
species of D3  were  detected in unstimulated cells (Fig. 5). 
Nevertheless, stimulation with either anti-Ig alone or anti- 
Ig  +  IL-4 produced  a  striking and  rapid induction  of cy- 
clins D2  and D3  (Fig. 5,  A  and  B),  closely resembling the 
results shown previously in Fig. 2. In B  cells cultured in IL-4 
alone,  cyclin D2  expression  was  induced  with  similar ki- 
412  Cell Cycle Regulation in B Lymphocytes Figure  4.  (A)  Induction  of cyclin- 
dependent  inhibitors.  Western  blots 
were  prepared as previously described, 
incubated  with  rabbit  antisera against 
p27, p21, or p19  inhibitors, then  pro- 
cessed as  described. P3X  was  used as 
positive control. The time in hours after 
stimulation  is  indicated.  Similar results 
were obtained in a second independent 
experiment.  (/3) Levels of p27 in  anti- 
IgM-  versus anti-CD40-stimulated  B 
cells. B cells were stimulated for times 
indicated with anti-IgM  (25 p,g/nil) or 
anti-CD40 (25 ~*g/ml)  in the absence of 
IL-4.  Western  blots were  prepared  as 
described in  Fig.  2.  Blots were  incu- 
bated with rabbit anti-p27 antibody and 
processed  as  described.  Similar results 
were obtained in a second experiment. 
netics,  i.e.,  by  3  h;  however,  the  induction  was  notably 
transient  in  nature  with  levels  reduced  by 6  h  (Fig.  5  A). 
Prolonged  but  weak  cyclin  D3  expression  was  observed 
(Fig.  5  /3).  Cyclin D 1 yeas not detected  under any stimula- 
tion  conditions  (Fig.  5  C).  These  data  indicate  that  IL-4 
causes  suboptimal  induction  of cyclins  D2  and  D3,  but 
does not achieve the sustained response obtained after anti- 
Ig stimulation. 
Discussion 
Antigen-specific  clonal  expansion  of B  lymphocytes is a 
critical  component  of antibody-mediated  humoral  immu- 
nity. The in vivo expansion of antigen-specific B  cells con- 
verts an initial B  cell precursor frequency  of",~l  in  10  s  (1) 
to a greatly expanded pool of cells in which individual pre- 
cursors have divided to as many as  104 daughter  cells (for a 
review  see reference  59).  To  extend  our understanding  of 
how this extensive clonal expansion is regulated, the current 
study  explores  the  induction  of cell  cycle  regulatory  pro- 
teins,  including  cyclins,  cdk,  and  cdk inhibitors,  in B  cells 
stimulated  in vitro specifically at their antigen  receptor us- 
ing anti-Ig antibodies.  This stimulus drives all B  cells,  irre- 
spective of their  antigen  specificity,  to  enter  the  G1  phase 
of cell cycle (5, 6),  with '--,50--60% continuing  on to com- 
plete the cell cycle and divide  (5, 6),  and then arrest in the 
G1  phase  of the subsequent  cycle  (7,  8).  To  minimize  the 
effects of dying cells throughout  the extended  96-h  culture 
period, anti-Ig-stimulated B  cells were cocultured with IL-4, 
a  viability-enhancing  cytokine  (19-22)  that  additionally 
truncates the G1 phase of cell cycle of anti-Ig-stimulated B 
cells  (7,  28,  29).  Our  data  indicate  that  the  type  and  se- 
quence  of cell  cycle  regulatory  proteins  expressed  in  B 
lymphocytes after stimulation with anti-Ig +  IL-4 was sim- 
ilar to those  characterized  in other cell systems, e.g.,  fibro- 
blasts or macrophages (for reviews see references 37,  38). B 
cells activated in this manner show a striking and synchro- 
nous  induction  of cyclins D2  and  D3,  but not D1,  occur- 
ring as rapidly as 3 h  after stimulation, above the low or un- 
detectable  amounts expressed in unstimulated large B  cells. 
An  indirect  indication  of D-associated  kinase  activity  can 
be obtained by examining the extent ofphosphorylation  of 
endogenous  tLb,  the  presumed  target  of cyclin  D-associ- 
ated kinase activity in vivo (51-54).  Surprisingly,  the phos- 
phorylation  of P,b,  initially  detected  in  our experiments  at 
18  h,  lagged  behind  the  induction  of cyclins  D2  and  D3 
and their associated kinases by at least "-,9 h  (Fig.  2).  Thus, 
despite the expression of all components required for effec- 
tive  cyclin/kinase  complex formation  at 9  h  after stimula- 
tion, no kinase activity detectable by endogenous kb  phos- 
phorylation  was  seen  until  late  G1  phase  (i.e.,  18  h  after 
stimulation).  This apparent lag in kinase activation may re- 
flect a  delay in the activation  of the  complex either by in- 
complete  assembly  or  lack  of  the  cdk-activating  kinase, 
CAK (60). Alternatively, the complexes may be blocked by 
inhibitors,  a proposal that is consistent with the appearance 
of p19 and p21 inhibitiors ,'o12 h  after stimulation with anti 
Ig  +  IL-4  (Fig.  4).  As  a  final  consideration,  it  is  possible 
that Rb  phosphorylation  does  not  accurately  reflect  D  ki- 
nase activity in B  lymphocytes. 
413  Solvason et al. Figure 5.  Induction  of Gl-associ- 
ated  cyclins  by  anti-lgM  alone  or 
IL-4 alone.  10  e' low density B cells/ 
ml were stimulated  with  10  Ixg/ml 
anti-lgM  plus  100  U/ml  IL-4,  10 
btg/ml anti-IgM alone, or 100 U/mI 
IL-4  alone.  An  abbreviated  time 
course  was  performed  with  lysates 
prepared  at (1,  3,  6,  10,  24,  30,  60, 
and  96 h  after stimulations.  125  Ixg 
of total  cell  lysate from  each  time 
point was  run  on  SDS-PAGE,  and 
Western  blots were prepared  as de- 
scribed  in  Fig.  2.  Blots  were  incu- 
bated with specific antibodies against 
cyclins D2 (A), D3 (B), and D1  ((~, 
and  processed  as  described  above. 
P3X  cells were  used  as  a  positive 
control  for  cyclins  I)2  and  1)3. 
NIH-3T3 cells were used as a posi- 
tive control  for cyclin D1. The time 
in  hours  after  stimulation  is  indi- 
cated. 
In addition  to  these  detailed analyses  of G1  phase  events 
in anti-Ig-stimulated B  cells, our experiments  also evaluate 
the appearance  of cell cycle regulatory proteins  controlling 
the  later  phases  of the  anti-Ig-induced  B  cell  cycle.  The 
expression  of  cyclin  E  and  its  kinase  partner  cdk2  was 
readily  evident by mid G1  phase  of the  anti-Ig-induced  B 
cell cycle (Fig. 3), consistent with other reports  (39).  How- 
ever,  we  could  not  detect  cdk2-associated  kinase  activity 
using the histone  substrate  assay  until cells had  entered  the 
S phase  of cell cycle, consistent with reports from Tanguay 
and  Chiles (61).  This delay in kinase  activation beyond the 
expression  of both  cyclin  and  kinase  protein  was  particu- 
larly  surprising,  since  cyclin  E/cdk2-associated  kinase  ac- 
tivity has  been  shown  in other systems  to  act  earlier in  the 
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possible explanation for the delayed appearance ofcdk2 ac- 
tivity is the observed induction of the inhibitor p21 at 15 h 
after stimulation (Fig.  4), since it has been shown in other 
cell systems that p21  inhibitor can be precipitated in com- 
plexes ofcyclin E/cdk2, and, under appropriate conditions, 
leads  to  inhibition  of cdk2  kinase  activity (62,  63).  In B 
cells stimulated with anti-Ig +  IL-4, cyclins A and 13, and 
their preferred kinase partner cdc2, were expressed at either 
the G1/S interphase (cyclin A and cdc2), or during S phase 
(cyclin B)  (Fig.  3).  In contrast to the delayed activation of 
cdk2, activation of cdc2 kinase activity correlated with pro- 
tein expression (Fig.  3),  in agreement with earlier reports 
on mitogen-stimulated human B cells (64). 
The data  described in  this  report represent one of the 
few analyses  to  date  describing cell cycle regulatory pro- 
teins in activated nontransformed lymphocytes. It provides 
a comprehensive evaluation of the full complement of cy- 
clins and cdk, as well as several of the cdk inhibitors, in ac- 
tivated  primary  B  lymphocytes.  Our  work  compliments 
that of Palermo  et al.  (65),  who previously investigated a 
panel  of human  B  lymphomas  and  found  that  they  ex- 
pressed cyclins D2 and/or D3, however, most lacked cyclin 
D1 expression. The few that did express cyclin D1, in fact, 
exhibited  the  t11,14,  or  bcl-1  translocation  (66,  67),  a 
chromosomal abnormality involving translocation of cyclin 
D1  on  chromosome  11  to  the  Ig  hea  W  chain  locus  on 
chromosome 14.  The pattern of D  cyclin regulatory pro- 
teins observed in anti-Ig-stimulated nontransformed B cells 
(e.g., Figs. 2 and 5) is similar to that expressed by nontrans- 
formed T lymphocytes after stimulation with mitogens (68, 
69).  However, this lymphoid pattern  of D  cyclin expres- 
sion  is  not  typical of all  hemopoietic  cells.  Considerable 
work has focused on the expression of cell cycle regulatory 
proteins in activated macrophages, and in this lineage, the 
cells  express cyclins D1  and D2,  but not  cyclin D3  (70). 
Since little  is  known  regarding the  functional differences 
between the D-type cyclins, the  significance of their lin- 
eage-restricted combinatorial expression is not understood. 
The  current  study  provides  further  insight  into  the 
mechanism by which IL-4 augments anti-Ig-induced B cell 
proliferation.  This  phenomenon  has  indeed  represented 
somewhat of a conundrum to date, since IL-4 is neither a 
growth factor per se, nor an obligatory competence factor. 
In  dissecting  the  effect of this  cytokine  on  the  anti-Ig- 
induced B  cell proliferative response, Rabin  et al.  (7,  28) 
have elegantly shown that IL-4, while incapable of driving 
B lymphocytes into S phase, dramatically truncates the G1 
phase of cell cycle. This property of IL-4 may well be ex- 
plained by our data showing that IL-4 induces transient and 
weak expression ofcyclins D2 and D3, respectively, in pri- 
mary B lymphocytes receiving no other exogenous stimu- 
lus  (Fig.  5), since previous studies in other cell types have 
clearly demonstrated that D cyclin induction is rate limiting 
in the progression to S phase (40, 41). 
Our data also provide a plausible molecular explanation 
for the previously documented G1  arrest that follows the 
initial proliferation of primary B cells in response to anti-Ig 
stimulation  (8).  In other cell systems,  G1  arrest is thought 
to be mediated at least in part by certain inhibitory mole- 
cules such as p27 (for a review see reference 46) with over- 
expression of p27 effectively causing G1  arrest in a variety 
of cell types (57,  71). As shown in Fig.  4, the reexpression 
of p27 at later time points with the exit of activated 13 cells 
from cell cycle and correlates with an accumulation of cells 
in G1 phase (Fig.  1). In contrast, p27 was destroyed with- 
out subsequent reexpression after stimulation ofB lympho- 
cytes  with  anti-CD40,  a  stimulant  capable  of inducing 
long-term B  cell proliferation  (Fig.  4  B)  These  data  are 
consistent with the notion that G1  arrest of anti-Ig-stimu- 
lated B  cells  after the  initial  round of replication may be 
mediated by p27  and,  conversely, that the ability of anti- 
CD40 to mediate long-term proliferation may be related to 
its ability to induce permanent downregulation of p27. 
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